NEWSFAQ for Our Disclosure on December 27, 2022, “GNI Group and Catalyst Biosciences Signed Agreements to Advance Liver Fibrosis Drug Development”
This Q&A is the same as the material previously published through TSE TDnet system on 2022/12/30.We’re re-posting it here as we stated in our original disclosure on 2022/12/27 that Q&A will be published to this section.